What Is Exagen Inc. (XGN) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, the balance of valuation evidence tilts cautious on Exagen Inc. at its current price of $4.14. The composite intrinsic value is estimated at $2.65 (-36.0% average return), with 8 models flagging overvaluation risk. The most optimistic model, PWERM, places fair value at $5.06 (+22.2%), while ML-RIV — the most conservative — estimates $0.06 (-98.6%). This +120.8% gap reflects genuine analytical uncertainty about Exagen Inc.'s intrinsic worth.
What Do the Models Say About XGN?
11 of 13 models are currently active for XGN. Of these, 3 models suggest upside while 8 models suggest overvaluation. The Bayesian DCF estimates XGN's intrinsic value at $0.76, implying -81.7% downside from the current price. See which stocks rank higher →
How Does XGN Rank in Services-Medical Laboratories?
Among 24 Services-Medical Laboratories stocks, XGN ranks #8 by Quality of Company score. CirclFi's QOC score of 7.0/10 evaluates 32 fundamental signals. A score of 7.0 indicates above-average quality.
Exagen Inc. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.
Is XGN a Value Trap?
CirclFi's Value Trap algorithm assigns XGN a score of 18/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
11 of 13 models are active for Exagen Inc.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi 32-factor quality framework, Exagen Inc.'s fundamental quality profile registers 7.0/10. This respectable score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.
The gap between the most bullish and bearish model spans +120.8% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every XGN valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across XGN's 11 active models, average confidence is 22%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad